1. Home
  2. MKSI vs NBIX Comparison

MKSI vs NBIX Comparison

Compare MKSI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MKS Instruments Inc.

MKSI

MKS Instruments Inc.

SELL

Current Price

$281.83

Market Cap

17.4B

Sector

Industrials

ML Signal

SELL

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$145.62

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKSI
NBIX
Founded
1961
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4B
15.5B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
MKSI
NBIX
Price
$281.83
$145.62
Analyst Decision
Buy
Strong Buy
Analyst Count
14
28
Target Price
★ $410.86
$207.81
AVG Volume (30 Days)
1.0M
★ 1.2M
Earning Date
11-04-2026
10-27-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
★ 55.52
41.95
EPS
★ 3.60
3.30
Revenue
★ $3,931,000,000.00
$161,626,000.00
Revenue This Year
$29.26
$36.49
Revenue Next Year
$20.69
$16.51
P/E Ratio
$75.34
★ $42.64
Revenue Growth
9.62
★ 977.51
52 Week Low
$121.28
$122.14
52 Week High
$447.62
$186.12

Technical Indicators

Market Signals
Indicator
MKSI
NBIX
Relative Strength Index (RSI) 59.07 45.12
Support Level $280.83 $125.85
Resistance Level $294.05 $161.41
Average True Range (ATR) 8.60 3.88
MACD 4.82 0.14
Stochastic Oscillator 95.43 43.89

Price Performance

Historical Comparison
MKSI
NBIX

About MKSI MKS Instruments Inc.

MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: